1980 Subject Index

American Pharmacy Volume NS 20 1980 Index·

The annual index is a single alphabetical listing of names and subjects. Numbers refer to the serial paging found with the title line at the bottom of each journal page.

Issue

Pages

3-56

January

57-112

February

Pages contained in each issue are shown below. Books reviewed are listed by title under the entry "Book Reviews." Nonproprietary drug names are used.

Issue

Pages

August

425-488

September

489-552

March

113-184

October

553-616

April

185-240

November

617-672

May

241-296

December

673-736

June

297-344

July [127th Annual Meeting Issue]

345-424

A Abood, Richard R., "Pharmacist Dispensing: Service or Sale?", 577-581 Abortifacients (new drugs), 175-176 Abrams, Mark, 498 Academy of Pharmaceutical Sciences, 389 awards, 364 new president, 364 Academy of Pharmacy Practice, 388-389 Long Term Care Section, 506, 507 National Medication Awareness Test, 646-647 new president, 364 Nuclear Pharmacy Section, 451, 452 Statement on Pharmaceutical Service in Home Health Care, 474 Accreditation standards for pharmacy schools, 511 Acetylcholine, 92 Acupuncture analgesia, 602-606 Acyclovir, for herpes infections, 248 Additives. See Food additives .

Adenosine receptors, 712 Adrenal gland tumors, me tyrosine therapy, 15 Adrenalin, 92-95 Adreon, Beatrice, 474 Schwartz Award Winner, 362, 364 Adverse drug reactions in the elderly, 256 Affective syndromes, 660-663 Aging, 249-278 aging process, 249-253 editorial, 244 letters, 429-430

research institutes, 252 White House Conference on, 258 See also Elderly persons. Agriculture Department, food labeling policy, 123 Ahlquist, Raymond, 92 Airline, Ralph W., 91 Albutoin,480 Alcohol consumption and nutrition, book, 239 and pregnancy, letter, 188-189 by elderly persons, 257 Alcohol cOI~tent of drug products, letter, 118 Alcohol-drug interactions, 687 and sleeping medications, 194-195

*Prepared by Sydney Schultz, MLS American Pharmacy Vol. NS20, No. 12, December 19801729

letter, 188-189

Allen, David, 452 Allergists, oppose NIH consensus development conferences, 43 Amantadine hydrochloride, for influenza, 46 Ambach, Gordon M., 542 Amcinonide (new drug), 175 American Association of Colleges of Pharmacy on BS degree, 523 on clinical pharmacy, 562 on competency, 560-561 programs on aging, 258 Standards of Practice, 360, 384, 50S, 508, 509, 527529, 533-536, 540, 549 American Association of Poison Control Centers, 68, 73,74 American Cancer Society, 206, 207, 209, 230, 679 and interferon research, 34, 35 American Council on Pharmaceutical Education, 506, 509, SIS, 538, 560 accreditation standards, 511 on continuing education programs, 534 American Health Care Association, unit dose report, 566

American Heart Association, and cholesterol, 330 American Institute of the History of Pharmacy award, 364

57

American Medical Association and physician advertising, 62 and postmarketing drug surveillance, 64 on HMOs, 595, 598 survey on geriatrics training, 253 American Pharmaceutical Association affiliated associations, 680 Board of Pharmaceutical Specialties, 380 Board of Trustees Honorary Chairman (Coghill), 65 competency program (Pennsylvania), 537-538 Computers for Pharmacy (book), 136 continuing education programs, 267, 380, 490 diabetics' eye care tip sheet, 606 diabetics' self-assessment program, 64 drug abuse policies, 691 Evaluations of Drug Interactions (book), 549, 551 Glaucoma Alert Program, 651-652 HEW drug projects, 374-375 Joint Commission on Prescription Drug Use, 64 National High Blood Pressure Education Program, 82-83, 86-87, 91, 381 on antisubstitution laws, 575-576 on chemical carcinogens regulation, 195 on clinical pharmacy, 562 on community pharmacy, 507 on Delaney Clause, 195 on drug abuse in skilled nursing facilities, 497-498 on expiration dating, 122 on health care television programs, 638-640 on home health care, 474 on mail-order financial and insurance services, 245 on methadone dispensing, 177-178 on national health insurance, ' 177 on nuclear pharmacy, 451-452 on old drug-new drug issue, 426 on patient education, 267, 317, 634 on patient package inserts, 626-627 on pharmacy theft prevention legislation, 690 on Project Sleep, 194-195, 696 on public health issues, 177-178, 375 on smoking, 431 on "therapeutic orphans," 433-434 on USP Convention, 305 Pharmacy Health Questionnaire, 219-221 Pharmacy Management Institute, 386 computers survey, 131-132, 138-139, 142 poison prevention activities, 66-67 relations with federal agencies, 378-379 international health care organizations, 379-380 national health care organizations, 378-379 state associations, 378 self-assessment activities for pharmacists, 533-534 Standards of Practice, 360, 384, 505, 508, 509, 527529, 533-536, 540, 549 Women in Pharmacy Task Force, 14, 359-360 American Pharmaceutical Association Annual Meeting Proceedings, 356-424 address of Board Chairman (Runge), 365-368 administrative operations, 390-392 announcement (1980), 101-108; (1981), 720-728 Annual Report, 369-397 awards, 362-364 bylaws revision, 391 Educational Affairs Committee Report, 399, 418-420 House of Delegates, 398-399 bylaws amended, 421 new business, 421 roster, 422-424 meeting highlights, 356-360 member services, 386-389 membership statistics, 391 policy issues, 372-375 Professional Affairs Committee Report, 398, 407413 programs and projects, 376-385 Public Affairs Committee Report, 399, 401-406 publications, 384-385 Scientific Affairs Committee Report, 399, 414-417 Treasurer's Report, 393-397 American Pharmacy (journal), 384 objectives, 6 American Public Health Association, on sexually transmitted diseases, 458 American Society of Consultant Pharmacists, 506 American Society of Hospital Pharmacists, 506 on clinical pharmacy, 562

58

search aid for computerized International Pharmaceu-

tical Abstracts, 566 Aminoglycosides, class labeling, 98 Aminopterin, letter, 347 Ampicillins class labeling, 98 for sexually transmitted diseases, 458, 462 patient package inserts, 626 Amygdalin, letter, 347-348 Analgesics endorphins, 286, 602-606 ibuprofen, 176 in hospice care, 323-325 morphine acetate, 664 new drugs, 170 use by elderly persons, 256 Anderson, Lowell J., 359, 691 "Special Recognition For Clinical Pharmacy As an Extension of Pharmacy Practice," 558-563 Androgens, class labeling, 98 Anfinsen, Chris, 35 Angina pectoris, 75-80, 712 propranolol therapy, 93 Angiotensin, 286 Annual implementation plan, letter, 676 Anorexics (nonamphetamine), class labeling, 98 Antibiotics new drugs, 169 piperacillin, clinical trials, 42 Anticancer drugs, 200-211, 213-217, 234, 318 Anticholinergics, class labeling, 98 Anticonvulsant drugs, 479-481 Anticonvulsant Screening Project, 481 Antidepressants, 98, 660-663 new drugs, 170-171 Antiepileptic drugs, 479-481 Antihistamines, class labeling, 98 Antihypertensives, 77, 78, 92-95 new drugs, 166-167, 171, 175 Antipsychotics, class labeling, 98 Antismoking devices, 669 Antisubstitution laws, 574-576 APhA Weekly (journal), 384 Appel, William F., 305 APhA Treasurer's Report, 393-397 Apple, William 5., 14, 24, 65, 195, 364, 375, 498 Archambault, George F., 305 Area health education centers program, 543-544, 546 Arena, Jay M., 436 Arizona Poison and Drug Information Center (University of Arizona College of Pharmacy), 71 Armstrong, George D., Jr., 29-30 "National Directions in Poison Control," 72-74 Army pharmacists at Cuban refugee centers, 656-657 Aronson, Don, 30 Aronson, Joel, 30 Arteriosclerosis, 75-80 Arthritis gold therapy, 482 penicillamine therapy, 176 tolmetin therapy, 176 Artificial sweeteners, 204, 623 Aschner, Bernhard, 285 Ascione, Frank J. "Home Medication Review," 266-267 "Seniors and Pharmacists: Improving the Dialogue," 270-272 Ascorbic acid, 179 Asher, William J., 48 Aspirin, and cardiovascular disease, 80, 288, 680 Aspirin Myocardial Infarction Study, 288 Asthma, summer camp for children, 333-336 Atherosclerosis, and sugar consumption, 50-51 Auranofin, for rheumatoid arthritis, 482 Austin, Spencer J., "Seniors and Pharmacists: Improving the Dialogue," 270-272 Automated data processing systems. See Computer systems for pharmacy. Awards, APhA, 362-364 Ayers, Frank, 494

B Bacon, William R., 24, 64 Baldassare, Andrew, 482 Bander, Les, 325

Barbiturates, 194, 195 class labeling, 98 Bardin, Wayne, 287 Barnett, Mark, 32 Barry, Estela, 466-468 Baum, Carlene, 283 Beal Award (William J. Skinner), 364 Beck, Robert J., "Drug Information Program Builds Skills," 54 Bectel, Maurice Q., 83 Belson, Joseph, 30-31 Benzodiazepines, 194, 195 class labeling, 98 patient package inserts, 626 use by elderly personS', 257 Bernstein, I. Leonard, 43 Bernstein, Lewis, 398 Berquist, Christer, 287 Bertin, Richard, 467 Beta blockers, 80, 92-95 Bilingual media programs, 641-643 Bioequivalence, 575, 628-633 letter, 117 Birth defects and Bendectin, 678 and drug addition in pregnancy, 197-199 and sleeping medications in pregnancy, 194-195 Bismuth sub salicylate, for diarrhea, 481 Bjelke, Erik, 231 Black Health Providers Task Force on High Blood Pressure Education and Control, 91 Blake, Edward M., 647 "Industry's Role in Continuing Competency," 540541 Blockstein, William L., (Rho Chi Award winner), 364 Blood pressure, 75-80 National High Blood Pressure Education Program, 82-83, 86-87, 91 Blue CrosslBlue Shield, 302 Bonadonna, Gianni, 205 Book Reviews Alcohol and the Diet, 239 Common Cures for Common Ailments, 339-340 Drug Interactions, 51 Drugs and the Elderly, 672 Earl Mindell's Vitamin Bible, 340 Economics of Medical Care, 51 Essential Guide to Prescription Drugs, 341-342 Family Prescription and Medication Guide, 342 Federal Regulation and Chemical Innovation, 612 Female Fix, 293 Fundamentals of Cancer Chemotherapy, 239 Handbook of Institutional Pharmacy Practice, 181 Hospice: Prescription for Terminal Care, 239 Iatrogenic Dieseses, 715 Medication Teaching Manual: A Guide for Patient Counseling, 715 Medicine Show, 339 Pharmacy: A Profession in Search of a Role, 612 Prescription Drugs, 342 Prescription Drugs in Short Supply, 672 Principles of Pharmaceutical Accounting, 612 Wigder's Guide to Over-the-Counter Drugs, 339 Your Medicine Chest, 340-341 Born, Gordon, 452 Bosworth, Barry P., 357, 398 Bowers, Roy A., 639 Bowles, Grover c., 397 Boylan, James E., 399 Brands, Allen J., 14 Breast Cancer, 205-206, 208-209, 227-230 in men, 227 Breast disease, and caffeine, 332 Breast self-examination, 229, 230 Brennan, Murray, 232 Britain, pharmacy in, 120-121 British National Formulary, 120 British National Health Service, 120 Bronchitis, sulfamethoxazole-trimethoprim therapy, 176 Brotman, Richard, 197-199 Browning, George, 158, 475 Brownlee, Michael, 664 Brugger, Joanne, 641 Brusadin, Ron, 159 Bulgaria, pharmacy in, 123 Bulk pharmaceuticals market, 307

American Pharmacy Vol. NS20, No. 12, December 19801730

Burke, Laurie, 30 Burkitt, Denis, 231, 330 Busse, Ewald W., "Eating in Late Life: Physiological and Psychological Factors," 276-278 Butler, Robert N., "The Gray Revolution and Health," 249-253 Buzzeo, Ronald, "Pharmaceutical Diversion: A Problem for the 1980s," 682-686 Byers, Theodore, 224

c Cachexia, in elderly persons, 274 Caffeine, 332 and pregnancy, 622 Cain, Dena, "Projecting the Public Image," 634 Calderon, Oscar, "Army Pharmacists at Cuban Refugee Centers," 656-657 Califano, Joseph, 65, 302, 314 California, home health care for elderly persons, 476478 Callaway, Wayne, 331 Cambodia, pharmacy and the refugees, 125-128 Cambodian Refugee Health Clearinghouse, 127 Camp TLC (Ohio), for asthmatic children, 333-336 Campbell, R. Keith, 606 Canaday, B.R., 544, 546 Cancer, 200-206, 210-211 and diet, 231-232 and smoking, 669, 679 hospice care, 323-325 interferon therapy, 34-35 patient counseling, 218 quackery in treating, editorial, 186 THC therapy, 306 Cancer chemotherapy, 200-211, 213-217, 234, 318 book,239 for breast cancer, 228, 230 in the elderly, 274 letters, 347-348 Cantrell, Kari, 34, 206 Capitation method of reimbursement, 510, 565 APhA report, 407-413 Carbamazepine, for epilepsy, 479, 480 Carbenicillin indanyl sodium, 176 Carbohydrate intake, and disease, 49-51 Carbo prost tromethamine (new drug), 175-176 Carcinogens, 200-204, 209, 231, 232, 624 in foods, 496, 622, 623 industrial, 202-203 APhA position on regulation of, 195 Cardiac arrhythmias, beta blocker therapy, 93-94 Cardiac glycosides, class labeling, 97 Cardiovascular disease, 75-80 and aspirin, 80, 288 beta blocker therapy, 92-95 National High Blood Pressure Education Program, 82-83, 86-87, 91 Carey, Hugh, 542 Carlin, Herbert 5., 305, 638, 640 Carroll, John B., 436 Carter, Jimmy on national health insurance, 16, 17, 438 on preventive health care, 314 Castle, Roy, 29 CAT scanners, 438, 439 Catastrophic health insurance, 16, 302-303, 438 Cavanaugh, Tom, 281, 284 Cefaclor (new drug), 169 Cefadroxil, 176 Center for Disease Control rabies treatment recommendations, 44-45, 432, 433 sexually transmitted diseases, 453-455, 460, 461 smallpox immunization, 625 Cephalosporins, class labeling, 97 Cerami, Anthony, 664 Chadduck, Harry W., 281 Chalmers, Robert K., "Pharmacy Education and the Future of Pharmacy," 504-509 Chemotherapeutic agents, 214 Child-resistant packaging, 436-437 Child safety, book, 436 Childhood diseases asthma, 333-336 cancer, 205 congenital heart disease, 75-80 diarrheal disease, 481

leukemia, 208 pharmaceutical services for, 381 tooth decay, 494 Childhood poison prevention, 66-74 Cholesterol, and cardiovascular disease, 75-80, 330 Chloral hydrate, 194 Christianson, Paul, 159 Cimetidine for duodenal ulcers, 495 patient package inserts, 626 Cinotti, Alfonse, 651 Citizens Alliance for VD Awareness, 458, 460 Class labeling, for prescription drugs, 96-98 Class 1-B drugs (new drugs), 166-169 Class 1-C drugs (new drugs), 169-171, 175 Clerkship programs, 514, 515 Cline, Peter, 466 Clinical pharmacy, 359, 558-563 APhA on cost effectiveness for, 421 APhA report on, 407-413 in Britain, 120-121 opportunities in, 24; panel discussion, 558-563 Professional liability, 548-551 Clinical toxicology, 74 Clofibrate, patient package inserts, 626 Clonazepam, for epilepsy, 480 Cobb, James, 30 Cocaine use, 687 Coghill, Marjorie M., 65, 364 Cohen, Arthur, 232 Cohen, Estelle, 14 Cohn, Jeffrey P. "A Battle With Cancer," 210-211 "Street Drugs," 692-695 Cold applications therapy, 470-473 Collins, Cardiss, 197 Community pharmacy, 505-508 APhA policy, 507 in cancer chemotherapy, 213-216 Competency projects, 384, 514, 526-538, 550, 551 Competitive health insurance proposals, 302-303, 438 Computer systems for pharmacy, 130-151, 358, 508 APhA publications, 136, 383 checklist, 151 cost-benefit issues, 141-146 legal and ethical issues, 140 letters, 300-301 Personal accounts, 156-159 PROPHET network, 358 selection of, 147-150 suppliers, 138-139 interview with, 152-155 types and uses, 132-137, 140 Computers for Pharmacy (book) 136, 383 Congenital heart disease, 75-80 Consumer drug in (ormation (FDA), 429 Consumer price index for pharmacy products, 290291 Consumer Product Safety Commission, and child-resistant packaging, 436 Consumer self-care movement, 308-316, 507 editorial, 298 books, 338-342 Contact lenses, soft lens care kit, 623-624 Contemporary Pharmacy Practice (journal), 384 Continuing education, 508, 526-529 APhA programs, 380 editorial, 490 Goyan on, 21 health personnel and, 543-544, 546 pharmaceutical industry involvement, 540-541 professional practice audit, 537-538 self-assessment, 533-536 state requirements, 531 Contraception, 287, 462 letters, 4, 117, 190, 301 Controlled substances and pharmacy robberies, 682-686, 690 Code of Federal Regulations, 690 DEA Pharmacist's Manual, 686 Controlled Substances Act of 1970, 682 Cooper, James, 359 Copayment programs, 17 Cope, James D., 122, 313 Coronary heart disease, 75-80 Cortisone synthesis, inventor honored, 248 Cost-benefit analysis

American Pharmacy Vol. NS20, No. 12, December 19801731

for clinical pharmacy, 421 for computer systems, 141-146 for health care projects, 564 Cost containment, 24, 247 editorial, 114 Crawford, D. Stephen, 399, 638-640 Crohn's disease, 482 Crossley, Ray, 32 Crout, J. Richard, 28, 192, 193, 305, 313, 632, 678 Cryotherapy, 470-473 Cuban refugees, pharmacy services for, 466-468, 656-657 Cutuly, Gene, "From the Viewpoint of a Supplier [of pharmacy computer systems]," 152-155 Cyclacillin (new drug), 169 Cyclamates, 195, 204, 623 Czechoslovakia, pharmacy in, 123 Czechowicz, Dorynne, 695

D Dale, Henry, 92 Danaher, Kate, 309 D' Angelo, Angele, 638, 639 Danowski, T.S., "Sugar and Disease," 49-51 Dantrolene sodium, 176 Dating of drugs. See Expiration dating. Davidson, Daniel, 623 Davignon, J. Paul, 306, 664 Day, Robert L., "Confessions of a Hardened FTC Witness," 590-592, 594 Deardorff, Dwight L., "First Impressions: Answering the Telephone," 649 Dee, Donald A., 636 "HMOs: Days of Future Passed," 595,598, 600-601 Degrees in pharmacy, 358-359, 512-514, 522-524 BS,517 Masters in public health, 608-609 PharmD, 509, 513 letter, 5 deGruy, David V., 697 Delaney, John, 496 Delaney Clause, 22, 496 APhA position, 195 DeLeon, Richard, 14 DelMedico, Joseph, 452 Dental hygiene, and fluorides, 494-495 Depressive illness, 660-663 Detroit pharmacists, exhibit at Republican National Convention, 640 Developing countries, and technology transfer, 10-11 DeVita, Vincent T., 208 "Cancer: The Curable Diseases," 200-206 Dexamethasone suppression test, for affective disorders, 663 Diabetes, and sugar consumption, 49-51 Diabetics APhA eye care information, 606 APhA monitoring program, 64 new insulin delivery system, 664 Diagnostic radiopaque agents, class labeling, 98 Dialysis, adjuncts to, 48 Diarrheal diseases, 481 Diazepam appearance of tablets, letters, 118, 349 prevention of succinylcholine side effects, 42 Diet and cancer, 231-232 and disease, 78, 329-332 fads, 329-332 of elderly persons, 276-278 Digestive disorders, 482 Digitalis, 256-257 Digoxin, 274 patient package inserts, 626 Dimmitt, Deanna, 324 Disease prevention, Surgeon General's report, 65 Dispensing information, APhA position, 305 Dispensing of drugs. See Pharmacist dispensing. Dispensing of INDs, for cancer chemotherapy, 214, 217 Dissolution standards, APhA position, 305 Ditchfield, Charles D., 537 Diuretics (new drugs), 166 Dodini, Luann K., "Clerkship Programs: Sharing Your Professional Knowledge and Skills," 515 Doering, Paul, 641

59

Dole, Robert, 438 Doluisio, James T., 638, 640 Dornan, Robert K., 197 Drug abuse, 692-695 in children, 637 in elderly persons, 254-257, 274 workshops, 697 Drug addiction, in pregnancy, 197-199 Drug costs, and national health insurance, 16, 17 Drug distribution, controlled substances, 682-686 Drug Efficacy Study Implementation review, 630 Drug Enforcement Administration computerized record keeping, 140 controlled substances programs, 682-686 Pharmacist's Manual, 686 Drug-food interactions, letter, 188-189 Drug information class labeling, 96-98 Federal Drug Index (FDA), 440 international communication of, 192-193 See also Patient package inserts Drug information centers, 67-74 Drug Information Service Center (University of Minnesota College of Pharmacy), 54 Drug interactions beta blockers, 95 book, 51 pharmacist knowledge of, 548-551 sleeping medications, 194 Drug product labeling alcohol content, letter, 118 expiration dating, 122 letter, 348 FDA actions, 29, 281 nonprescription drugs, 502, 590-594 prescription drugs, 96-98 Drug product quality, 224-226, 439-440 Drug product recalls, 30-31, 407-413, 441-443 Drug product review, 45, 192-193 Drug product selection 572-576 APhA policy, 374 Drug product testing, 433-434 anticancer drugs, 201-206 FDA activities, 28-32 Drug profiles, and professional liability, 548-551 Drug Regulation Reform Act of 1979,23, 177, 178, 440 APM policy 373-374 Drug regulations, 305 book, 612 legislation APM policy, 373-374 Goyan on, 23 Drug sampling, FDA programs, 224-226 Drug surveillance systems, 64 Dubow, Lawrence, 640 Dumouchel, Paul, 359 Duodenal ulcers, cimetidine therapy, 495 Durenberger, David, 302, 303, 438

Endogenous morphine, 286, 602-606 Endogenous opiate system, 603 Endorphins, 286, 602-606 England, pharmacy in, 120-121 Engman, Lewis A., 63 Enkephalins, 286, 603 Enthoven, Alain, 302 Environmental factors, and cancer, 202-203 Epilepsy, drug screening project, 479-481 Epinephrine, 92-95 Equity for pharmacists, APM programs, 376-377 Equity theory of motivation, 483-485 Erythromycin class labeling, 98 patient package inserts, 668 Estrogen patient package inserts, FDA survey, 318-322 Ethyl nitrite ether, 623 Etidronate disodium, 176 Europe, pharmacy in, 123 Expectancy theory of motivation, 483-485 Expiration dating, 122 letter, 348 Eye care for diabetics, 606

F

Family planning information, letters, 4, 117, 190, 301 Family psychiatric history, 660-663 Farrell, Paul, 467 Fats (dietary), and disease, 231, 329-330 Featherstone, Mary J., 494 Federal Trade Commission food labeling policy, 123 health services regulation, 62-63 nonprescription drug advertising, 502, 590-594 primer on Robinson-Patman Act, 584-589 Feinberg, Madeline, " Elder Ed," 264-265 Feldmann, Edward G., 195, 305 "FDA: Policeman or Teacher," 7 Feldstein, Martin, 302 Ferguson, Tom, "The Self-Care Revolution," 308-311 Ferrer, Joan, 656 Fiber (dietary), 330-331 and colon cancer, 231 Field, Frank, 638 Field, Pam, 638 Fink, Joseph L. , III, 550, 580 "Crimes Against Pharmacies-A Review" , 700-701 Finnegan, Loretta P., 198, 199 Fisher, Bernard, 205 Fisher, Edwin, 205 Florey, Klaus G. , 364 Flu. See Influenza. Fluorides, 494-495 letter, 621 Flurazepam, 194 Flynn-Breeden, Linda, "Home Medication Review," 266-267 Food additives, 22, 329-332, 622 E Food and Drug Administration East Germany, pharmacy in, 123 Commissioner Goyan, interview, 18-24 Eastep, Roger, 29 drug approval process, 10, 30, 45, 426 Eastern Europe, pharmacy in, 123 letters, 556-557 Eating habits, in elderly persons, 276-278 Drug Bulletin, 551 Ebert Prize (Cheng-Der Yu), 364 drug misuse radio and television programs, 642 Edloe, Leonard L., 14, 157-158 Drug Quality Assurance Project, 224-226 Edwards, Charles c., 499, 590 drug recall system, 30-31, 441-443 Edwards, William J., 398, 399 Federal Drug Index, 440 Elderly persons, 249-278 Good Manufacturing Practices, 22, 224-226, 447, alcohol consumption, 257 448 drug use, 252, 254-257, 497-498 history, 25-26 book,672 INDINDA regulations, 25, 29, 45, 433 health care, 247, 251-253, 260, 494 international communication of drug information, home health care, 270-272, 474-478 192-193 nutrition, 273-278 new drugs approved, 165-171, 175-176 patient information, 264-266 organization chart, 27 pharmaceutical services for, 254-257, 507 pharmacists employed by, 27-32 Eldred, John 5., 628 letter, 118 Ellwood, Paul, Jr., 600 Poison Control Division, 30 Emergency Medical Services Division, Health Serpriorities, survey, 627 vices Administration, poison control activities, professional relations unit telephone number, 429, 74 443 Emigh, James F., 452, 646, 647, 691 relations with health professionals, 23-24 Employee competence, 716-718 role, editorial, 7 Employer-paid health insurance, 302-303 Food and Drug Administration actions on Emswiller, Carl, 325, 668 alcohol-drug interactions, 188-189

60

anticancer drug trials, 201-205 beta blockers for hypertension, 95 caffeine, 622 carcinogens, 203 cimetidine, 495 class labeling, 96-98 cyclamates, 623 drug labeling, 29 drug recalls, 30-31, 441-443 expiration dating, 122 florides, 495 food labeling, 123, 332 food safety testing, 496 gentian violet, 624 iron intake, 566 laetrile, 186 "man-in-the-plant" rule, 434 medical technologies, 438-440 methadone, 177 metyrosine, 15 new drugs, 165-171, 175-176 nitrites, 622 nonprescription drugs, 499-502 nonprescription drugs, advertising, 593 patient package inserts, 29, 177, 318-322, 626-627, 668 peptidestesting, 287 prescription drugs, advertising, 280-284 rabies vaccine, 432, 433 radiopharmaceuticals, 398-399, 444-452 ritodrine hydrochloride, 625 soft contact lens kits, 623-624 sulfinpyrazone for heart attacks, 288 sunlamps, 307 sweet spirits of nitre, 623 theophylline, 568 "therapeutic orphans," 433-434 unapproved nonproprietary drugs, 628-633 USP, 305 vitamins and minerals, 118 Food, Drug, and Cosmetic Act of 1938, 45, 282, 445, 446, 628-633 Delaney Clause, 22, 496 APhA position, 195 Kefauver-Harris Amendments, to, 280, 630-631 Medical Device Amendments, 438 Food-drug interactions in elderly persons, 273-275 letter, 188-189 Food labeling, 332 APhA report, 414-417 FDA policy, 123 Food Safety Council, 496 Food safety testing systems, 496 Forbes, Dave, "Managing the Marginal Employee," 716-718 Forman, Jody, 199 Formularies British National Formulary, 120 Fox, Jeffrey L. , 364 Framingham study, 624 Francke, Donald E., 563 Frankel, Robert, 28-29, 45, 433 Freedman, George, 475 Freis, Edward D., 332 Fry, John, 312 Fryer, James, 91

G Gaetano, Ron, 640 Gagnon, Jean Paul, "Third-Party ReimbursementsHow Did We Get Where We Are Today?", 703-710 Garrettson, Lome K., 436 Gastrointestinal tract stimulants (new drugs), 168-169 Generic drugs. See Nonproprietary drugs. Generix Drug case, 631-632 Genital herpes simplex, 42 Gentian violet, 624 Gerbino, Philip P., 359 "Special Recognition For Clinical Pharmacy As a Collection of Subspecialties," 558-563 Geriatric medicine, 249-253 Gerontology Research Center (NIA), 251 Gibbs, Paul, "Estrogen PPIs: An FDA Survey," 318-322

American Pharmacy Vol. NS20, No. 12, December 19801732

Gibbs, Robert G., 636 Gibson, Melvin R, 258 Gilbertson, William E., 31, 499-502 Glaucoma, 651-652 THC therapy, 306 timolol maleate therapy, 94, 95 Glaucoma Alert Program, 651-652 Glucocorticoids, class labeling, 97 Glutethimide, 194 Gold therapy, for rheumatoid arthritis, 482 Goldstein, Avram, 605 Gomori, George, 285 Gonorrhea, 454, 455, 461 Good Manufacturing Practices (FDA), 122, 224-226, 447,448 Goodman, Jane, 610 Gore, Albert, Jr., 441 Gosselin, Raymond, 639 Gottleib, Norman L., 482 Goyan, Jere E. (FDA Commissioner), 7, 25, 28, 45, 305, 441, 443, 501, 502, 561, 568, 622, 623, 626, 627, 642 APhA Annual Meeting remarks, 357 interview, 18-24 letter, 118 Schaefer Award winner, 362 Gracely, Richard H., 606 Graduate programs in pharmacy, 522-524 "Grandfathered" drugs, 630 Great Britain, pharmacy in, 120-121 Griffin, Don, 475 Griffenhagen, George B., 364 Groft, Steven, 29 Grollman, Arthur, 590 Gross, Stephen M., "Graduate Education: Formal Study Beyond Pharmacy School," 522-524 Grossman, Leonard, 156-157 Gumbhir, Ashok K., "MPH: An Attractive Alternative," 608-609 Gutterman, Jordan, 35

H Hallucinogenic drug use, 692-695 Haloperidol tablets, letters, 118, 349 Halperin, Jerome A., 28, 192, 193, 398, 399 "Regulatory Problems With Radiopharmaceuticals," 444-449 Halsted, William, 200, 227, 228 Hamilton, Howard, 652 Hamilton, Richard, 122, 693 Harris, Charles Stuart-, 46 Harris, Patricia Roberts, 15, 566, 626, 627 APhA Annual Meeting remarks, 357 Hatch, Clyde J., 91 Hatch, Orrin, 373 Health and Human Services Department [forme~ly HEW],15 MAC program, 439 on drug use in skilled nursing facilities, 497-498 on HMOs, 595 Health care costs, 16, 17, 249-253, 302-303, 438-440, 564 editorial, 114 economics, book, 51 for elderly persons, 249-253 in Britain, 120-121 in Cambodia, 125-128 in Eastern Europe, 123 in Hungary, 36-40 insurance, 302-303 national issues, 247 Surgeon General's report, 65, 314 Health Care Financing Administration, 439, 601 on hospices, 324 on medication reviews for Medicaid patients, 497-498 on payments for allergy procedures, 43 Health, Education, and Welfare Department becomes HHS, 15 drug projects and APhA policy, 374-375 standards for long-term care facilities, 506 "Health Field" television series, 638-640, 647 Health foods, 123 Health insurance proposals, 302-303 Health maintenance organizations, 16, 303, 439, 595598, 600-601

pharmaceutical services in, 596-597, 600-601 Health Maintenance Organization Act of 1973, 598 Health Manpower Act of 1968, 510 Health Planning and Resources Act of 1974, 439 Development Amendments of 1979, 248 Health professions, and FTC actions, 62-63 Health systems agencies, planning cycles, 248 Heart disease, 75-80, 680 beta blocker therapy, 80, 92-95 Heat applications therapy, 470-473 Heating pads, 472 Heller, William M., 305 Hellman, Sidney, 228 Hemophilus influenzae, 711-712 Hendeles, Leslie, 568 Henney, Jane E., 664 Hepatitis vaccine, efficacy trials, 713-714 Herbal tea, 123 Herbert, Daniel A., 158-159, 213-217 Heroin use, 687, 692-695 for pain relief, 664 in pregnancy, 198 Herpes infections, 42, 248, 458, 461 Herrmann, Arthur P., 452 Herzberg, F., 99-100 Heterotopic ossification, etidronate disodium therapy, 176 Hicks, David, 475 High blood pressure, 75-80 National High Blood Pressure Education Program, 82-83, 86-87, 91 Higuchi, William I., 364 Hill, Beverly E., 643 Hill-Burton Act, 438 Hilleman, Maurice, 713-714 Hiner, Elizabeth, 32 Ho, Norman F. H ., 364 Hogan, Linda, "Tips on Writing Patient Information," 648 Hohmann, John R, 30 Holistic health movement. See Consumer self-care. Holmes, King K., 454 Home health agencies, 476-478, 507 Home health care cancer patients, 218 insurance coverage, 324 pharmaceutical services, 266-267, 272, 474-478 Hong Kong influenza virus, 46 Hood, Lee, 35 Hopps, Hope, 35 Hormones, in cancer chemotherapy, 208, 209 peptide hormones, 285-287 Horvath, Denes, 40 Hospices, 323-325 book,239

Hospital pharmacy, 505, 506 book, 181

Hot water bottles, 472 Huffman, B. Leslie, Jr., 309 Hufstedtler, Shirley, 15 Hughes, John, 603 Hughes, Richard L., 247 Humphrey Award (George H. Ryan), 362 Hungary, pharmacy in, 36-40, 123 Hurley, Laurence H ., 234 Hurwitz, Herbert 5., 436 Hussi;lr, Daniel A., 399, 638, 640 "Important New Drugs of the Year," 165-171, 175-176 Hyaluronidase, and cardiovascular disease, 80 Hydrocollators, 471 Hydrocortisone, 500 Hypertension, 75-80 beta blocker therapy, 80, 92-95 and diet, 331-332 letters, 245 National High Blood Pressure Education Program, 82-83, 86-87, 91 new drugs, 166-167 rat research, 180 SAPhA programs, 610-611 Hypertension Detection and Follow-Up Program, 75-80 Hyperthermia (malignant), dantrolene sodium therapy,176 Hyperthyroidism, beta blocker therapy, 94 Hypnotic analgesia, 606

American Pharmacy Vol. NS20, No. 12, December 19801733

Hypnotics, 194-195 Hypoglycemia, 50, 331

I Iannarelli, Cynthia, 610 "Counseling the Cancer Patient," 218 Ibuprofen, 176 Ice packs, 473 Illicit drugs, 682-686, 687, 692-695 Immunity to disease and vitamin C, 179 sex differences, 180 Immunization education, SAPhA program, 611 Immunotherapy, 209 Inaba, Darryl 5., 695 Indigent cancer patient programs, 215 Infant formula recall, 441-443 Infants nutrition, corrections to October 1979 article, 4 withdrawal symptoms, 199 Inflation, and pharmacy revenues, 290-291 Influenza A virus, amantadine hydrochloride therapy,46 Inge, Leonard, 91 Insomnia, 194-195 Institute of Medicine, National Academy of Sciences on gerontology training, 253 sleeping medication report, 194-195 Institutional pharmacy, book, 181 Insulin delivery systems, 664 Insulins, class labeling, 98 Interferon for cancer, 206 for viral infections, 33-35 synthesized, 179 Internal Revenue Service drug deduction, APhA report, 401-406 International Committee of the Red Cross, in Cambodia, 125-128 International Pharmaceutical Abstracts (journal), computer search aid, 566 International pharmacy Britain, 120-121 Cambodia, 125-128 communication, 192-193 Cuban refugees, 466-468, 656-657 Eastern Europe, 123 Hungary, 36-40 research, 10-11 Investigational new drugs (lNDs) for cancer chemotherapy, 214, 217 for radiopharmaceuticals, 445-450, 452 procedures and regulations, 224, 433 Iowa capitation study, 565 Ipecac syrup, 67, 69 Iron intake, 566 Iron storage disease, 714 Irwin, Robert, 447 Isaacs, Alick, 33, 206

J Jackson, George Gee, 46 James, Mary, "Seniors and Pharmacists: Improving the Dialogue," 270-272 Javits, Jacob, 510 Jenkin, Patrick, "British Health Chief Urges Larger Clinical Pharmacy Role," 120-121 Jepsen, Roger, 690 Johnson, C. Anderson "Motivating the Pharmacy Employee," 52-53 "Herzberg's Theory of Hygienes and Motivators," 99-100 Johnson, Douglas P., 636 Johnson, Karen, 311 Johnson, Virginia Bates, "Drug Product Selection Through the Decades," 572-576 Joint Commission on Accreditation of Hospital Standards, 506 Joint Commission on Prescription Drug Use, final report, 64 Jones, Janet, 29 Jones, Judith, 30 Journal of Pharmaceutical Sciences (journal), 384 Jucker, E. M., "Let's Not Give Away Our Pharmaceutical Technology," 10-11

61

K Kabay, Janos, 39 Kaiser Foundation HMO Plan, 595 Kalman, Samuel H., 646 "Lifetime of Learning," 526-527 Kansas Pharmacists Association, association president's views, 222-223 Kasperson, Richard W., 623 Katzoff, Jack, "A Pharmacist In a Home Health Agency," 476-478 Kefauver-Harris Amendments, 10, 280, 630-631 Kempner, Walter, 332 Kennedy, Donald, 45, 623 Kennedy, Edward M., 258, 510 and national health insurance, 16, 17, 64, 303, 438 Kennedy, J. Stephen, 195, 695, 696 "Awakening the Nation to Sleep Problems," 696 Kershner, Lorraine M., "Cancer: The Curable Diseases," 200-206 Kidney disease, liquid membrane therapy, 48 Kimminau, Michael D., "New Findings on Oral Dosing," 463-465 Kirk, Kenneth W., 14 Klein, Otto G., Jr., 606 Knapp, Gene, 31 Knox, Alan B., "Self-Directed Learning," 535-536 Kogut, John A., 14 Konnor, Charma, 31-32 Koprowski, Hilary, 44 Kosterlitz, Hans, 603 Koustenis, Gust G., 443 Kozel, Nicholas, 687, 692-695 Kozel, Steve, 611 Krause, Richard, 43 Krauthammer, Charles, 194 Kremers Award Gohn Parascandola), 364 Kuperminc, Mario, 213 Kupferberg, Harvey, 481 Kushner, Dan, 364

L Labeling alcohol content of drug products, 118 expiration dating, 122, 438 FDA actions, 29, 281 nonprescription drugs, 502, 590-594 prescription drugs, 96-98 See also Patient package inserts. Labrie, Fernand, 287 Lactulose syrup, 176 Laderman, Ross 5., 443 Laetrile editorial, 186 letter, 347-348

Lais, Lyman T., 180 Laminar flow hoods, 213-214, 348 Lambert, Randall L. "Motivating the Pharmacy Employee," 52-53 "Herzberg's Theory of Hygienes and Motivators," 99-100 Lamy, Peter P., 498 "Misuse and Abuse of Drugs by the Elderly," 254-257 Lannett Company case, 631 Lao, Chang, "Estrogen PPIs: An FDA Survey, " 318-322 Large volume parenterals, 421 Lasagna, Louis, 590, 605 La Valle, Kenneth, 542 Laxatives lactulose syrup, 176 Lessing, Melvin, 31, 32 Leverty, Don, "Cambodia: Pharmacy and the Refugees," 125-128 Levin, Lowell, 309 Levine, Jerome I., 32 Levine, Jon D., 605, 606 Levy, Robert I., 288, 330 "Preventing the Preventable: Cardiovascular Disease," 75-80 Lewis, Benjamin P., Jr., 29 "Class Labeling: FDA Concepts and Approach," 96-98 Libow, Leslie, 253

62

Licensing of pharmacists, reciprocity, 418-420 Life style and cancer, 202-203 and cardiovascular disease, 75-83, 86-87, 91 Lindenmann, Jean, 33, 206 Liner, Milton, 30 Lipman, Arthur, 323, 359 Lippman, Marc, 208 Lipsitz, Ruth, 307 Liquid membrane capsules, for uremia, 48, 246 Lithium, 495, 660, 662 Local anesthetics, class labeling, 98 Long, Russell B., 16, 303, 438 Long-term care, 265-266, 272, 505, 506 APhA programs, 380-381 drug use in, 497-498 HEW programs, 374-375 Longe, R Leon, "Basics of Patient Counseling," 315-316 Loos, H. Clifford, 595 Lurvey, Patricia, "Managing the Marginal Employee," 716-718 Luteinizing hormone releasing hormone (LHRH), 285-287 Lutgen, Timothy A, "Motivating the Pharmacy Employee: Expectancy and Equity Theories," 483-485

M Magno, Josefina, 323-325 Mail-order financial and insurance services, letter, 245 Mail-order pharmacy, litigation, 390-391 Maine, Lucinda L., 14, 195, 691 Maisel, Georg 5., "Update on Child-Resistant Packaging," 436-437 Manic-depressive illness, 495, 660-663 "Man-in-the-plant" rule, 434 Manzella, John P., 179 Marcarelli, Joseph L., 598 Marginal employees, 716-718 Marijuana illicit use, 687, 692-695 medicinal use, 306, 414-417 Marshall, Bob, 647 Martin, Daniel, 205 Martin, James, 302, 303 Marwick, Charles 5., "Hepatitis Vaccine Trials," 713-714 Maryland Poison Information Center (University of Maryland School of Pharmacy), 66, 70 Maslow, AH., 483, 484 Matsen, John M., 42 Maximum Allowable Cost, 439, 440 Mayer, David, 604, 606 McGregor, D., 52-53 Media programs, 635-643 Medicaid-Medicare and HMOs, 601 and home health care, 474, 475 and long-term care facilities, 497, 498, 506 and national health insurance, 16, 302-303, 438-440 patient package inserts costs, 626 reimbursement by capitation, 565 Medical technologies, assessment and regulation, 438-440 Medvedev, Z.A, 278 Mendieta, Ezequiel, 466-468 Merigan, Tom, 35 Metaproterenol, for asthma, 92 Methadone, 197 APhA position, 177-178 Methapyrilene, 203 Methaqualone, 194, 687 Methoxsalen, patient package inserts, 626 Metoclopramide hydrochloride (new drug), 168-169 Metroprolol, for hypertension, 94, 95 Metyrosine (new drug), 167-168 for pheochromocytoma, 15 Metzenbaum, Howard, 510 Mexiletine, 480 Michels, Daniel, 224-226 Michigan health care programs for the elderly, 270-272 Middleton, John K., "HMOs: Days of Future Passed," 595, 598, 600-601

Migraine headache, propranolol therapy, 176 Miller, Gus H., "Devices to Help Smokers Stop Don't," 669

Miller, Jacob W., 398 Miller, Roger B., 642 "Stomping the Bushes Kansas Style," 222-223 Miller, Sanford, 22, 332 Miller, Vandy, 452 Milliequivalents, letter, 60 Milliken, William G., 270 Millis, John 5., 505 Millis Study Commission on Pharmacy, 505, 517, 522, 524 Millstein, Lloyd, 29 Minnesota HMO plans, 600-601 Minoxidil (new drug), 166-167 Minton, John, 332 Mirsky, Howard, 458 "Pharmacists and VD control," 460-462 Mitscher, Lester A., 364 Mobile Mental Health Center, 697 Molthan, Nean, 610 Monoamine oxidase inhibitors, 660, 663 Moore, Steven R, "Consumer Testing of a Prototype PPI," 668 Morphine acetate, 664 Morphine sulfate, 664 Morris, Louis A, "Estrogen PPIs: An FDA Survey," 318-322 Mosso, Joseph A. (Smith Award Winner), 364 Motise, Paul, 122 Motivation of pharmacy employees, 52-53, 99-100, 483-485 Motivator-hygiene theory, 99-100 Mullane, Mary Kelly, 14, 359 Multiple-drug use by the elderly, 256, 257 Munsey, Rodney R, 628 Murphy, Gary J., 656 Murphy, Joseph, 695 Muscle relaxant drugs, side effects, 42 Myers, Ann, 29 "Estrogen PPIs: An FDA Survey," 318-322 Myers, Mary Nelson, 474, 475 Myocardial infarction, 75-80 and aspirin, 80, 288 beta blocker therapy, 94

N Nadolol (new drug), 171, 175 for hypertension, 95 Nalbuphine hydrochloride (new drug), 170 Naloxone, 602-606 Narcotics analgesics, class labeling, 98 Narcotics use, 692-695 Nash, Dan, 306 National Academy of Sciences, Institute of Medicine on gerontology training, 253 sleeping medication report, 194-195 National Association of Chain Drug Stores, 508 National Cancer Institute and anticancer drugs, 200-206, 232, 234 and laetrile, 186 and marijuana therapy, 306 prevention program, 202-204, 230 National Center for Health Care Technology, 439 National Center for Health Statistics, childhood poisoning data, 66 National Clearinghouse for Poison Control Centers, 71, 72 National Conference on High Blood Pressure Control, 86-87 National Heart, Lung, and Blood Institute, 75-80, 83, 87 National health insurance, 16, 17, 302-303, 438-440 APhA position, 177 National health planning goals, Surgeon General's report, 65 National High Blood Pressure Education Program, 78, 82-83, 86-87, 91 APhA involvement, 381 National High Blood Pressure Month, 91 National Hospice Organization, 323-325 National Institute of Dental Research, study on fluorides, 494-495 National Institute of Neurological and Communicative Disorders and Stroke, 479-481

American Pharmacy Vol. NS20, No. 12, December 19801734

National Institute on Aging, 251-253 National Institute on Alcohol Abuse and Alcoholism, publications, 188-189 National Institute on Drug Abuse, 687, 692-695 drug use data, 687 National Institutes of Health concensus development conferences; 43 on amantadine, 46 National Medication Awareness Test, 383, 634, 638, 646-647 National Poison Center Network, 68-70 National Poison Prevention Week, 66-67, 73-74 APhA participation, 381 National Wholesale Druggists' Association, computer use survey, 132, 135 Needs-hierarchy theory, 483, 484 Nelson, Gaylord, 282 Neu, Harold c., 42 Neumark, Phil, 590, 591 Neuromuscular blocking agents, class labeling, 98 New Drug Applications (NDAs), 224, 433 for nonproprietary drugs, 628-633 for radiopharmaceuticals, 445-450, 452 New Drug Evaluations Office (FDA), 28-29 New drugs costs, 114, 301 information for pharmacists, 407-413 rate of introduction, 10 See also "Therapeutic orphans." New drugs approved (as of January 1, 1980), 165-171, 175-176 Ng, Lorenz, 602, 603 Nicotine, 669 Nitrites, 622 Nona, Daniel A., "Time to Focus on an Overlooked Accreditation Standard," 511 Nonprescription drugs advertising, 62-63, 246, 401-406, 502, 590-594 expiration dating, 122 FDA review, 499-503 Nonprescription vitamins and minerals, letter, 118 Nonproprietary drugs, 575-576 advertising, 283 unapproved drugs, conference, 628-633 Norepinephrine, 92 North Carolina Area Health Education Centers Program, 543-544, 546 Norwood, G. Joseph, 565 Novitch, Mark, 23 Nuclear medicine, 444-452 Nuclear pharmacy, 360, 380, 398-399, 444-452 APhA reports, 407-413, 451-452 Nuclear Pharmacy Practice Standards, 451, 452 Nuclear Regulatory Commission, 449, 451-452 Nurse Training Act of 1979, 14 Nutrition and alcohol, book, 239 and qmcer therapy, 231-232 corrections to October 1979 article, 4 dietary fads, 329-332 and the elderly, 273-278 food labeling, 123, 332, 414-417 iron intake, 566 vitamins and minerals, letter, 118 Nygren, Kathy, 611

o Obesity and health, 624 and sugar consumption, 49-51, 331 drug-induced, in the elderly, 274 Oderda, Gary M., "Regional [poison] Centers Answer the Challenge," 67-70 Office of Technology Assessment, report on health costs, 564 Old age. See Aging; Elderly persons. Opiate receptors, 603 Oral anticoagulants, class labeling, 97 Oral dosing devices, 463-465 Oregon State University School of Pharmacy, hyper. tension research, 180 Organic medicinal compounds, 568 Orlans, Melvin H., 63 Orphan drugs, 479-480, 566 Orr, William, 696 Osteoarthritis, tolmetin therapy, 176

OTC drugs. See Nonprescription drugs. Oxytocin, 286

p Pain control cold versus heat treatments, 470-473 morphine acetate, 664 THC,306 endorphins, 286, 602-606 in hospices, 323-325 hypnosis, 606 placebo effects, 604-606 Pain medications, for elderly persons, 256 Palacios, Ada Marie, 656 Palumbo, Francis B., "Promoting Rational Drug Use [for the elderly]," 265-266 Pan-American Health Organization, international communication of drug information, 192-193 Paoloni, Claude U., "North Carolina AHEC Model: Pipeline for Pharmacy Education," 543-544, 546 Parascandola, John (Kremers Award winner), 364 Parker, Luther R., 636 Parkinsonism, amantadine therapy, 46 Parkman, Paul, 44 Parrish, Richard H., II, "Camp TLC: Helping Children [with asthma] Help Themselves," 333-336 Patient care, monitoring, 381 Patient education, 4, 21-23, 189-190,527,618,634-643, 646-652 APhA projects, 317, 383 asthma, 333-336 cancer, 206, 215-216, 218, 230 Drug Information Service Center (Minnesota), 54 elderly persons, 254-257, 264-266 family planning, 4, 117, 190, 301 high blood pressure, 75-80, 82-83, 86-87, 91 home health care, 315-316, 475 hospices, 323-325 oral dosing devices, 465 pharmacy health questionnaire, 219-221 pregnancy, 199 poison control, 67-74 Poison Information Center (Maryland), 66, 70 sexually transmitted diseases, 455, 458, 460-462 sleeping medications, 696 smoking, 430-431 Patient medication records APhA project, 384 professional liability, 548-551 Patient package inserts, 177, 357, 439, 440 APhA policy, 372-373 estrogen, 318-322 FDA on, 29, 177, 281, 318-322, 440, 626-627, 668 Goyan on, 21, 23, 357 prototype, 668 Peckman, Richard D., 399 Pena, Jaime, 656 Penicillamine, 176 Penicillinase-resistant penicillins, class labeling, 98 Penicillins class labeling, 98 for sexually transmitted diseases, 458, 461-462 Penna, Richard P., 23, 122, 195, 497, 498 Pennsylvania Pharmacists Professional Development Program, 537-538 Penry, J. Kiffin, 479 Pepper, Claude, 497 Peptide hormones, 285-287 Perez, Thomas H., 29, 466-468 Perry, Seymour, 43 Personal Drug Information Checklist, APhA program, 381 Pert, Agu, 602 Pert, Candace, 603 Pertschuk, Michael, 62, 63 Peterson, William, 30 Petrusek, Ruby L., 234 Pfeifer, Eugene M., 628 Pharmaceutical associations, poison prevention activities, 66-67 Pharmaceutical diversion, 682-686, 690, 691 editorial, 674 Pharmaceutical manufacturers and FDA quality assurance programs, 224-226 and pharmacy continuing education programs, 540-541

American Pharmacy Vol. NS20, No. 12, December 19801735

"man-in-the-plant" rule, 434 Pharmaceutical Manufacturers Association, 632 letters, 189-190 on estrogen patient package inserts, 318 on expiration dating, 122 Pharmaceutical research, 10-11 Pharmaceutical services, for the elderly, 247, 254-257 mandatory, 60 reimbursement, 24, 302-303, 357, 407-413, 439-440, 474-475, 498, 506-508, 510, 565 See also International pharmacy. Pharmaceutical technology, 10-11 Pharmacist dispensing, 576-581 APhA report, 401-406 letter, 348 Pharmacists in FDA, 23-24, 27-32 legislative awareness, 292 monitoring diabetic patients, 64 professional responsibilities, 177-178 public health issues, 177-178 role in cancer chemotherapy, 213-216 role in care of elderly persons, 254-267, 270-272 role in consumer self-care, 308-316 role in high blood pressure education, 82-83, 86-87, 91 role in home health care, 474-478 role in hospice care, 323-325 role in poison prevention, 66-71 role in postmarketing drug surveillance, 64 role in skilled nursing facilities, 374-375 self-assessment programs, 384, 526-536 sex education information, 4, 117, 190, 301 telephone services, 649 travel assistance, 326-328 Pharmacy College Admission Test, 517, 542-543 Pharmacy education, 504-546 area health education centers programs, 543-544, 546 clerkships, 514, 515 for clinical pharmacy, 550, 562-563 Goyan on, 21 graduate education, 522-524 internship/externship programs, 195 letters, 5, 60, 620 programs on aging, 258-263 self-directed programs, 526-536 undergraduate education, 512-514 Pharmacy exhibit, Republican National Convention, 640 Pharmacy Health Questionnaire, 219-221 Pharmacy malpractice, 548-551 letters, 620-621 Pharmacy management book, 612 community pharmacies, 508 federal price standards, 233-234 inflation, 290-291 Uniform Cost Accounting System, 382-383 Pharmacy Management Institute, 386 computers survey, 131, 132, 138-139, 142 Pharmacy personnel management, 52-53, 99-100 483-485, 716-718 Pharmacy products, consumer price indexes, 290-291 Pharmacy schools accreditation standards, 511 Arkansas, poison prevention activities, 67 Arizona, Poison and Drug Information Center, 71 admissions tests, 517, 542-543 curriculum changes, 508-509 Duquesne, poison prevention activities, 67 federal assistance, 510 Maryland, poison information center, 66, 70; drug education for the elderly, 264-266 Michigan, home medication review, 266-267 Minnesota, Drug Information Service Center, 54 Oregon State, hypertension research, 180 Pittsburgh, poison prevention activities, 67 programs on aging, 258, 260-262 Samford, poison prevention activities, 67 SAPhA programs, 610-611 Washington, DC area alumni, 306 Pharmacy students federal assistance, 510 1978-1979 SAPhA programs, 610-611 Pharmacy thefts, 700-701

63

Pharmacy theft prevention programs, 682-686, 690 APhA position, 401-406, 690 in Kansas, 685 legislation, 690 Pharmadyne Laboratories case, 631 Phencyclidine use, 687 Phenytoin for epilepsy, 479, 481 patient package inserts, 626 Pheochromocytoma, metyrosine therapy, IS, 167-168 Physican dispensing, APhA action, 421 Picchioni, Albert L., "The Oldest 'New' Program in Poison Control," 71 Pietrusko, Robert G., "Professional Practice Audit," 537-538 Pines, Wayne, 622 Pinworms, gentian violet therapy, 624 Piperacillin, 42 Poison Control Division, FDA, 72-74 Poison prevention, 66-74, 437 FDA programs, 30, 72-74 information centers, 67-74 SAPhA programs, 610 APhA poster, 697 Poison Prevention Packaging Act of 1970,66, 74,436, 437 Poke root herbal tea, 123 Poland, pharmacy in, 123 Pollin, William, 692 Porter, Roger J., 480 Portis, Kattie, 199 Postmarketing drug surveillance systems, 64 Potassium preparations class labeling, 98 letter, 430 Potter, John, 323 Powers, James B., 635 Powers, Justin L., 305 Prednisone, for Crohn's disease, 482 Pregnant Addicts and Addicted Mothers program (New York), 197-199 Pregnancy and alcohol, 188-189 and amantadine hydrochloride, 46 and caffeine, 622 drug addiction in, 197-199 sleeping medications, 194-195 Premature labor, ritodrine hydrochloride therapy, 625 Premo Laboratories case, 631-632

editorial, 426

Psychotropic drugs, 660-663 use by elderly persons, 274 Public health graduate education in, 608-609 Surgeon General's report, 65 Public Health Service assistance for Cuban refugees, 467, 468 pharmacy officer to become Assistant Surgeon General, 14 Public relations activities, 635-649 APhA programs, 377-378 Publications, APhA, 384-385 Purtilo, David T., 180 Purvis, Bill, 281-284 Pyrantel pamoate, 624

Q Quinidine salts, class labeling, 98

R Rabies vaccine, 44-45, 432, 433 Rachanow, Gerald M., 31, 32 Radiation therapy, 209, 228 Radio programs on pharmacy, 635-636, 641-643 Radiopharmaceuticals, 398-399, 444-452 Ragettli, Janos, 40 Randall, Robert, 306 Rauwolfia alkaloids, class labeling, 98 Reagan, Ronald, nealth policies, 677 Reciprocity in licensing of pharmacists, 399 APhA report, 418-420 Red Cross, International Committee in Cambodia, 125-128 Reifman, Ann, 495 Reimbursement. See Pharmaceutical services, reimbursement. Reinders, Thomas P., 87, 359, 475 "Clerkship Programs: Sharing Your Professional Knowledge and Skills," 515 Remington Medal Ooseph D. Williams), 362 Research on Aging Act of 1974, 253 Rever, Philip R., "Truth-in-Testing or Admissions Prescriptions?" 542-543 Rheinstein, Peter H., 281-284 Rheumatic heart disease, 75-80 Rheumatoid arthritis gold therapy, 482 penicillamine therapy, 176 Rho Chi Society award (William L. Blockstein), 364

Prepackaging, letter, 5 Prescription drug products advertising, 280-284 class labeling, 96-98 letter, 620 expiration dating, 122 given nonprescription status, 500-501 Rhodes, Christopher, 313, 639 identification, APhA report, 399, 401-406 Richburg, Max N. reimbursement programs, 439-440 "FTC's Proposed Drug Advertising Rule," 593 shortages, book, 672 "Observations By an Industry Attorney," 594 Richmond, Julius, 127, 195, 696 White House Conference, 691 Prescription Drug Use, Joint Commission, final re- Riddiough, Michael A., "Federal Control of Medical Technologies," 438-440 port, 64 Preventive health care, Surgeon General's report, 65 Ritodrine hydrochloride, for premature labor, 625 Robbins, Jack, 518 See also Consumer self-care. Preyer, Richardson, 16 Roberts, Norbert J., Jr., 179 Price discrimination, Robinson-Patman Act, 584-589 Robinson-Patman Act, 584-589 Rodbell, Stanley, 695 Price posting, 177, 283-284 Roe, Daphne A., "Nutrition and Chronic Drug AdPrice standards for pharmacies, 233-234 ministration: Effects on the Geriatric Patient," Professional liability, 548-551 273-275 Professionalism in pharmacy, 21-24, 177-178, 222-223, Romania, pharmacy in, 123 516-518, 537-538 Roney, Joseph, 640 book, 612 Rosen, David L. , 32 editorial, 490 Rosenberg, E. William, 313 letter, 676 Ross, David E., 537 Professional Standards Review Organizations, 439 Ross, Donald, 595 Project Sleep, 194-195, 696 Rotavirus, 481 PROPHET [computer network], 358 Rottenberg, Simon, 313 Propoxyphene, patient package inserts, 626 Rozsnyay, Matyas, 40 Propranolol, 176 Rubin, Melvin N ., 691 for cardiovascular disease, 80, 92-95 Runge, Mary Munson, 14, 305, 359, 362, 364, 638-640 Proprietary Association "The Pharmacist and Professional Citizenship," and expiration dating, 122 177-178 and nonprescription drug labeling, 502 "We Shall Overcome!" [APhA Annual Meeting and self-medication, 312 address], 365-368 Proprietary drugs, advertising, 283 Prostatitis, carbenicillin indanyl sodium therapy, 176 Russia, pharmacy in, 123 Ryan, George H . (Humphrey Award winner), 362 Psychopharmacology, 660-663

64

s Sabatini, Gloria, 14 Saccharin, 204, 623 Sacks, Philip, 399, 560, 561 Salerno, Evelyn, 324-325 Salt consumption, and disease, 331-332 Salt tablet kit, for soft contact lenses, 623-624 Samford University College of Pharmacy, SAPhA project, 610-611 Sammons, James H., 356 Sanford, Jay, 46 Sarett, Lewis H., 248 Saturated fats, and cancer, 231 Sauer, Gordy, 325 Schaefer Award Oere E. Goyan), 362 Schaeffer, Leonard D., APhA Annual Meeting remarks, 357 Schein, Philip, 210-211 Schiffman, Susan, 277 Schistosomiasis, 679 Schizophrenia, 660-663 Schlegel, John F., 498 "Generations of Pharmacists," 516-518 "Pharmacy Education [programs on aging]," 258 Schmidt, Alexander, 568, 623 Schulman, Jerome, 46 Schulman, Michael, 590, 591 Schumacher, Gerald E., 550 Schwartz, Gerald A., "Pharmacy Malpractice: The Changing Standard of Care," 548-551 Schwartz Award (Beatrice Adreon), 362, 364 Schwartz College of Pharmacy, SAPhA project, 610-611 Schweiker, Richard, 302, 303, 510 Seaman, John J., "Professional Practice Audit," 537-538 Sehnert, Keith, 312 Selenium, and cancer, 232 Self-care. See Consumer self-care. Sex differences in immunity to disease, 180 Sex education, letters, 4, 117, 190, 301 Sexually transmitted diseases, 453-455, 458-462 letters, 620, 676 Shadid, Michael, 595 Shalinsky, Joseph, 685 Shaw, Stanley, 452 Sherman, Max, "Hot or Cold: Which Treatment to Recommend?" 470-473 Shimp, Leslie A. "Home Medication Review," 266-267 "Seniors and Pharmacists: Improving the Dialogue," 270-272 Siecker, Bruce R., 398 "Computers for Pharmacy," 130-151 Silverstone, Leon M., 494 Sims, Elizabeth, 325 Skilled nursing facilities, drug reviews in, 374-375, 497-498 See also Long-term care. Skin infections, cefadroxil therapy, 176 Skinner, William J. (Beal Award winner), 364 Sleep disorders, 696 Project Sleep, 194-195, 696 Sleeping medications, 194-195, 696 Small, William E., 195 Smallpox vaccinations, 625 . Smith, Edward, 30 Smith, Harry A., "Inflation Gauge: Measuring Growth in the Pharmacy," 290-291 Smith, Michael Ira, 14 Smith, Mickey c. , 364 Smith, Robert, 359 Smith, Roxie, 534 Smith Award Ooseph A. Mosso), 364 Smoking antismoking devices, 669 and cardiovascular diseases, 78-79

letter, 430-431 Snyder, Solomon, 603 Society of Nuclear Medicine, 448 Solomon, David, 474 Soloway, Albert, 358 Somatostatin, 285 Sorlie, Paul, 624 South Dakota University, SAPhA project, 610-611

American Pharmacy Vol. NS20, No. 12, December 19801736

Soviet Union, pharmacy in, 123 Spanish-language media programs, 641-643 Spectinomycin, for sexually transmitted diseases, 458 Spirit of nitrous ether, 623 Sporn, Michael, 231 Stalpes, Bunny, "Learning About the Elderly: Closing the Gaps," 259-263 Stamm, J. W., 494 Standards for Certification ·of Skilled Nursing Facilities, 506 Standards of Practice for the Profession of Pharmacy, 360,384,505,508,509,527-529,533-536,540,549 State pharmaceutical associations, 378 Stewart, Jesse E., 248 Stimmel, Glen L., 359 "Special Recognition for Clinical Pharmacy as a General Specialty," 558-563 Stovall, Larry, 156 Strander, Hans, 34, 206 Street drugs, 687, 692-695 Strokes, 75-80 Stryker, Joan c., 198, 199 Stuart-Harris, Charles, 46 Student American Pharmaceutical Association, 389 annual meeting announcement, 104 on computers, 132 poison prevention activities, 67 1978-1979 programs, 610-611 Student Committee on Drug Abuse (University of Maryland School of Pharmacy), 698 Study Commission on Pharmacy, 505, 517, 522, 524 Succinylcholine, side effects, 42 Sugar consumption, 49-51, 331

letter, 5 Sulfamethoxazole-trimethoprim, 176 Sulfasalazine, for Crohn's disease, 482 Sulfinpyrazone, for heart attacks, 288 Sulfonamides, class labeling, 98 Sullivan, John L., 180 Sulthiame,48O Sunlamp hazards, 307 Surgeon General's Report on Health Promotion and Disease Prevention, 65, 314 Sussott, Daniel, 127 Svarstad, Bonnie, 14 Sweet spirits of nitre, 623 Swinyard, Ewart, 480, 481 Syphilis, 460-461 ~zmuness, Wolf, 713-714

T Targum, Steven D., "Family Tree Gives Clues to Treating Psychoses," 660-663 Taurine, letter, 59-60 Taylor, A. Thomas, "Basics of Patient Counseling," 315-316 Television programs on pharmacy, 635-640, 642, 643 Terbutaline, for asthma, 92 Tetracyclines class labeling, 97 for sexually transmitted diseases, 458, 462 Texas Pharmaceutical Association, public relations activities, 643 Tham, Anna, 611 THC, 694 for cancer and glaucoma, 306 Theophylline dosages, 568 "Therapeutic orphans," 433-434 APhA report, 414-417 Thermotherapy, 470-473 Thiazides class labeling, 98 patient package inserts, 626 Third-party payments, 247, 302-303, 357-358, 440, 703-710 APhA programs, 377, 383, 398 Throat products, letter, 4 Thyroid hormones, class labeling, 98 Thyrotropin-releasing hormone (TRH), 285 Ticrynafen (new drug), 166 recall, 441-443 Timolol maleate, for glaucoma, 94, 95 Torus, Edward, 306 Tommasello, Tony, 693 "Maryland's Student Committee on Drug Abuse (SCODAE)," 698

Tooth decay, and fluorides, 494-495 Tolmetin, 176 Topical corticosteroids, 175 class labeling, 98 Torrico, Susan, 364 T6th, George, "Pharmacy and Health Care in Hungary," 36-40 Toxicology, 74 Trace minerals, and cancer, 232 Trapnell, Gordon R., 17 Tricyclic antidepressants, 660-663 class labeling, 98 Trimipramine maleate (new drug), 170-171 Trosclair, Gary P., 32 Trowell, Hugh, 231 Trudeau, Terry, ''Tips for the Traveling Professional," 326-328 ''Truth-in-testing'' legislation, 542-543 Twycross, Robert G., 324, 664 Tyson, James N., 91

u

Wertheimer, Albert I., 123 "Herzberg's Theory of Hygienes and Motivators," 99-100 "Motivating the Pharmacy Employee," 52-53 White, Eugene, 668 White House Conference on Aging, 258 White House Conference on Prescription Drug Misuse, Abuse, and Diversion, 691 Willette, Robert, 306 Williams, Joseph D. (Remington Medalist), 362 Williams, Ronald L., "Keeping High Blood Pressure On the Run," 82-83, 86-87, 91 Williamson, John D., 309 Williamson, Robert c., "Pharmaceutical Diverson: A Problem for the 198Os," 682-686 Wilson, Phyllis, 157 Winkler, William G., 44, 45 Witkor, Tadeusz J., 44 Wodicka, Virgil 0., 496 Wolf, Harold H., 64 Women atherosclerosis in, 51 drug addiction in, 197-199 health issues, book, 436 immunity to disease, 180 prescription drug use, book, 293 Women in pharmacy, 65 APhA programs, 14, 359-360 377 World Health Organizations international communication of drug information, 192-193 on rabies, 44, 432 training programs, 38 Wyatt, Richard Jed, 495 Wynder, Ernst, 231

Ulene, Art, 643 Ullman, Al, 302, 303 Uniform Cost Accounting System, 382-383 Unit dose drug distribution systems, 566 United Kingdom, pharmacy in, 120-121 United Nations Conference on Trade and Development, and drug technology transfer to developing countries, 10-11 United States PharmacopeiaiNational Formulary, 30, 224, 305 Addendum Guly 1980), 305 Dispensing Information, 549, 551 Product Problem Reporting Program, 288, 443, 448 United States Pharmacopeial Convention, 305 y on patient package inserts, 627 ------------------University of California at San Francisco, SAPhA Yandle, Bruce, 313 project, 610-611 Yellin, Arthur, 281-284 University of Florida, radio programs on health, 641 Yen, Samuel, 287 University of Minnesota, SAPhA project, 610-611 Yu, Cheng-Der (Ebert Prize winner), 364 University of Montana, SAPhA project, 610-611 Yugoslavia, pharmacy in, 123 University of North Carolina, area health education centers program, 543-544, 546 University of Southern California, SAPhA project, 610-611 Zoon, Katherine, 33 Upton, Arthur, 330 Uremia, liquid membrane therapy, 48 USSR, pharmacy in, 123

z

V

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ Vacca, Patricia c., 452 Valproic acid, 479 Vasopressin, 286 Venereal diseases, 453-455, 458-462 Viral infections and vitamin C, 179 interferon therapy, 33-35 Virginia Commonwealth University, clerkship program, 515 Virginia State Board of Pharmacy case, 283 Vitamin C, 179 Vitamins and cancer, 231-232 deficiencies in elderly persons, 275 FDA report, letter, 118

w Walker, Donna J., "Raise Your Voice for Pharmacy," 292 Warfarin, patient package inserts, 626 Waxman, Henry A. , 23, 510, 664 Weaver, Lawrence c., "Undergraduate Education: A Look To the Future," 512-514 Webb, C. Edwin, "North Carolina AHEC Model: Pipeline for Pharmacy Education," 543-544, 546 Weight, and health, 624 Weinberger, Miles, 568 Welch, Armond M., 32 Wellness movement. See Consumer self-care. Wells, Ken, 610 Wernik, Donald, 651